Bicyclol

• CAT Number: I000644
• CAS Number: 118159-48-1
• Molecular Formula: C19H18O9
• Molecular Weight: 390.30
• Purity: ≥95%
• Synonyms: 5/’-(hydroxymethyl)-7,7/’-dimethoxy-[4,4/’-bi-1,3-benzodioxole]-5-carboxylic acid, methyl ester
• Target: HBV
• Solubility: DMSO: ≥ 68 mg/mL
• Storage: -20°C
• IUPAC Name: methyl 4-[5-(hydroxymethyl)-7-methoxy-1,3-benzodioxol-4-yl]-7-methoxy-1,3-benzodioxole-5-carboxylate
• InChI: InChI=1S/C19H18O9/c1-22-11-4-9(6-20)13(17-15(11)25-7-27-17)14-10(19(21)24-3)5-12(23-2)16-18(14)28-8-26-16/h4-5,20H,6-8H2,1-3H3
• InChIKey: KXMTXZACPVCDMH-UHFFFAOYSA-N
• SMILES: COC1=C2C(=C(C(=C1)CO)C3=C4C(=C(C=C3C(=O)OC)OC)OCO4)OCO2

Bicyclol（Cat No.:I000644）is a hepatoprotective agent widely used for the treatment of chronic liver diseases, including viral hepatitis and drug-induced liver injury. It works by inhibiting oxidative stress, stabilizing cell membranes, and modulating inflammatory pathways, thereby reducing liver damage and promoting regeneration. Bicyclol also exhibits antiviral properties by suppressing hepatitis B and C virus replication. Its excellent safety profile, oral bioavailability, and minimal side effects make it a preferred choice for long-term liver protection. Bicyclol is a valuable therapeutic option in managing liver health and preventing disease progression.

Reference

[1]. Walsh, S.W., Y. Wang, and A. Killian, AA-2414, an antioxidant and thromboxane receptor blocker, completely inhibits peroxide-induced vasoconstriction in the human placenta. J Pharmacol Exp Ther, 1999. 290(1): p. 220-6.